Nivolumab in patients (Pts) with relapsed or refractory classical Hodgkin lymphoma (R/R cHL): Clinical outcomes from extended follow-up of a phase 1 study (CA209-039) Meeting Abstract
| Authors: | Ansell, S.; Armand, P.; Timmerman, J. M.; Shipp, M. A.; Garelik, M. B. B.; Zhu, L. L.; Lesokhin, A. M. |
| Abstract Title: | Nivolumab in patients (Pts) with relapsed or refractory classical Hodgkin lymphoma (R/R cHL): Clinical outcomes from extended follow-up of a phase 1 study (CA209-039) |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019002020 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.583.583 |
| Notes: | Meeting Abstract: 583 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
